- Presentations
- 4
- Markets
- 1
Coreg CR is a brand of Carvedilol marketed by Waylis Therapeutics, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Carvedilol
- Brand owner
- Waylis Therapeutics
- Registered in
- United States
- Strengths and forms
- 10 mg extended-release capsule, 20 mg extended-release capsule, 40 mg extended-release capsule, 80 mg extended-release capsule
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Coreg CR 10 mg extended-release capsuleOral | Waylis Therapeutics | US FDA | Available on request |
| Coreg CR 20 mg extended-release capsuleOral | Waylis Therapeutics | US FDA | Available on request |
| Coreg CR 40 mg extended-release capsuleOral | Waylis Therapeutics | US FDA | Available on request |
| Coreg CR 80 mg extended-release capsuleOral | Waylis Therapeutics | US FDA | Available on request |
Equivalent brands
Other brands of Carvedilol.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Coreg CR
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.